Hypoxia stimulates the synthesis of cytochrome P450-derived inflammatory eicosanoids in rabbit corneal epithelium.

The corneal epithelium metabolizes arachidonic acid by a cytochrome P450-(CYP) mediated pathway to 12(R)hydroxy-5,8,10,14-eicosatrienoic acid [12(R)-HETE] and 12(R)hydroxy-5,8,14-eicosatrienoic acid [12(R)-HETrE]. Both metabolites possess potent inflammatory properties with 12(R)-HETrE being a powerful angiogenic factor and assume the role of inflammatory mediators in hypoxia- and chemical-induced injury in the cornea, in vivo. We developed an in vitro model of corneal organ culture to characterize the biochemical and molecular events involved in the increased synthesis of these metabolites. These cultured corneas exhibit epithelial cytochrome P450 CYP-dependent 12(R)-HETE and 12(R)-HETrE synthesis as indicated by chiral analysis and by the ability of CYP enzyme inhibitors to repress their synthesis. Hypoxia greatly and selectively stimulated the synthesis of 12(R)-HETE (7-fold over control normoxic conditions) and 12(R)-HETrE. The bacterial endotoxin, lipopolysaccharide, also increased the synthesis of these eicosanoids, substantiating the notion that this activity may function as an inflammatory pathway. These metabolites were detected in the culture medium by gas chromatography/mass spectroscopy (GC/MS) analysis and their levels significantly increased in hypoxia-treated corneas, further indicating their endogenous formation in response to injury. This in vitro model provides an excellent preparation for studying factors regulating the synthesis of these inflammatory eicosanoids and for isolating, identifying and characterizing the CYP protein responsible for their synthesis.

[1]  M. Schwartzman,et al.  Hypoxia-induced production of 12-hydroxyeicosanoids in the corneal epithelium: involvement of a cytochrome P-4504B1 isoform. , 1999, The Journal of pharmacology and experimental therapeutics.

[2]  M. Schwartzman,et al.  Alkali burn-induced synthesis of inflammatory eicosanoids in rabbit corneal epithelium. , 1997, Investigative ophthalmology & visual science.

[3]  D. Koop,et al.  Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression. , 1997, Journal of Pharmacology and Experimental Therapeutics.

[4]  M. Schwartzman Cytochrome P450 and Arachidonic Acid Metabolism in the Corneal Epithelium , 1997 .

[5]  R. Billings,et al.  Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450. , 1996, Molecular pharmacology.

[6]  M. Schwartzman,et al.  Chiral analysis of 12-hydroxyeicosatetraenoic acid formed by calf corneal epithelial microsomes. , 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[7]  J. Rosenberg,et al.  A closed eye contact lens model of corneal inflammation. Part 1: Increased synthesis of cytochrome P450 arachidonic acid metabolites. , 1995, Investigative ophthalmology & visual science.

[8]  N. Abraham,et al.  A closed eye contact lens model of corneal inflammation. Part 2: Inhibition of cytochrome P450 arachidonic acid metabolism alleviates inflammatory sequelae. , 1995, Investigative ophthalmology & visual science.

[9]  J. Falck,et al.  Enhancement of delayed hypersensitivity inflammatory reactions in guinea pig skin by 12(R)-hydroxy-5,8,14-eicosatrienoic acid. , 1995, The Journal of investigative dermatology.

[10]  S. Yamamoto,et al.  Oxidation and keto reduction of 12-hydroxy-5,8,10,14-eicosatetraenoic acids in bovine corneal epithelial microsomes. , 1994, Biochimica et biophysica acta.

[11]  M. Schwartzman,et al.  Effect of metabolic inhibitors on arachidonic acid metabolism in the corneal epithelium: evidence for cytochrome P450-mediated reactions. , 1994, Journal of ocular pharmacology.

[12]  H. Shichi,et al.  Synthesis of 12(R)- and 12(S)-hydroxyeicosatetraenoic acid by porcine ocular tissues. , 1994, Journal of ocular pharmacology.

[13]  J. Vane,et al.  Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Y. H. Wang,et al.  The effect of copper ion on arachidonic acid metabolism in the porcine corneal epithelium. , 1993, Biochemical and biophysical research communications.

[15]  E. Morgan Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo. Independence from the hypothalamo-pituitary axis. , 1993, Biochemical pharmacology.

[16]  L. Chauvelot‐Moachon,et al.  Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat. , 1992, Biochemical pharmacology.

[17]  R. Murphy,et al.  Metabolism of 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid (12(R)-HETE) in corneal tissues: formation of novel metabolites. , 1991, Archives of biochemistry and biophysics.

[18]  N. Abraham,et al.  Detection of 20-hydroxyeicosatetraenoic acid in rat urine. , 1991, Biochemical and Biophysical Research Communications - BBRC.

[19]  Paine Aj The cytochrome P450 gene superfamily. , 1991 .

[20]  H. Bazan,et al.  The epithelium, endothelium, and stroma of the rabbit cornea generate (12S)-hydroxyeicosatetraenoic acid as the main lipoxygenase metabolite in response to injury. , 1991, The Journal of biological chemistry.

[21]  T. Inoue,et al.  Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase. , 1991, Journal of medicinal chemistry.

[22]  P. Janssen,et al.  NADPH-dependent formation of 15- and 12-hydroxyeicosatrienoic acid from arachidonic acid by rat epidermal microsomes. , 1991, Eicosanoids.

[23]  A. Paine The cytochrome P450 gene superfamily. , 1991, International journal of experimental pathology.

[24]  W. Powell,et al.  Metabolism of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid and other hydroxylated fatty acids by the reductase pathway in porcine polymorphonuclear leukocytes. , 1990, Biochemistry.

[25]  M. Holtzman,et al.  A regiospecific monooxygenase with novel stereopreference is the major pathway for arachidonic acid oxygenation in isolated epidermal cells. , 1989, The Journal of clinical investigation.

[26]  B. Holden The Glenn A. Fry Award Lecture 1988: The Ocular Response to Contact Lens Wear , 1989, Optometry and vision science : official publication of the American Academy of Optometry.

[27]  J. Masferrer,et al.  Synthesis and Structure Confirmation Of Compound D, A Proinflammatory Arachidonate Metabolite , 1989 .

[28]  K. Proctor,et al.  Cardiovascular and renal actions of cytochrome P-450 metabolites of arachidonic acid. , 1989, Blood vessels.

[29]  P. Woollard,et al.  Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12‐hydroxy‐5,8,10,14‐eicosatetraenoic acid , 1988, British journal of pharmacology.

[30]  G. Higgs,et al.  Eicosanoids and inflammation , 1988, The Journal of pathology.

[31]  P. Woollard,et al.  Psoriatic skin lesions contain a novel lipid neutrophil chemokinetic compound which is distinct from known chemoattractant eicosanoids , 1988, British journal of pharmacology.

[32]  L. Marnett,et al.  Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism. , 1988, Archives of biochemistry and biophysics.

[33]  J. Masferrer,et al.  12(R)-hydroxyicosatetraenoic acid: a cytochrome-P450-dependent arachidonate metabolite that inhibits Na+,K+-ATPase in the cornea. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Woollard,et al.  12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid is a chemoattractant for human polymorphonuclear leucocytes in vitro. , 1987, Prostaglandins.

[35]  G. Waring,et al.  Patterns of pathologic response in the cornea. , 1987, Survey of ophthalmology.

[36]  J. Falck,et al.  Absolute configuration of the hydroxyeicosatetraenoic acids (HETEs) formed during catalytic oxygenation of arachidonic acid by microsomal cytochrome P-450. , 1986, Biochemical and biophysical research communications.

[37]  P. Woollard Stereochemical difference between 12-hydroxy-5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesions. , 1986, Biochemical and biophysical research communications.

[38]  P. Ortiz de Montellano,et al.  Specific inactivation of hepatic fatty acid hydroxylases by acetylenic fatty acids. , 1984, The Journal of biological chemistry.

[39]  P. Woollard,et al.  The identification of hydroxy fatty acids in psoriatic skin. , 1983, Prostaglandins.

[40]  F C Kauffman,et al.  Factors regulating drug metabolism in intact hepatocytes. , 1979, Pharmacological reviews.

[41]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.